Current Neuro-Oncology

Volume 26 Number 29
20 December 2024

Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 29, 20 December

Di Carlo D, Annereau M, Vignes M, Denis L, Epaillard N, Dumont S, Guyon D, Rieutord A, Jacobs S, Salomon V, Yoldjian I, Duperray F, Brunel L, Baiao X, Lemos F, Vauleon E, Capra M, Abbou S, Touat M, Sanson M, Gandemer V, De Carli E, Bourdeaut F, Hezam I, Vassal G, Grill J.
Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.
Eur J Cancer. 2024 Dec 11;216:115165. doi: 10.1016/j.ejca.2024.115165. PMID: 39700833. Compassionate use. ˍ

Jang HJ, Moon BJ, Park M, Joo B, Kim KH, Suh SH, Ahn SJ.
Transdural location as a predictor of recurrence in spinal cord meningiomas.
J Clin Neurosci. 2024 Dec 11;132:110975. doi: 10.1016/j.jocn.2024.110975? PMID: 39667314. Observational study˰ ˍ

Kakouri A, Chen Y, McCulley TJ.
Isolated Hemifacial Spasm as the Presenting Sign of Cerebral Glioblastoma.
Ophthalmic Plast Reconstr Surg. 2024 Dec 11. doi: 10.1097/IOP.0000000000002838. PMID: 39660646. Case report˰ ˍ

Li T, Zhao Z, Peng M, Zhang L, Wang C, Luo F, Zeng M, Sun K, Fang Z, Luo Y, Xie Y, Lv C, Wang J, Huang J-D, Zhou H, Sun H.
Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma.
mSystems. 2024 Dec 11:e0045724. doi: 10.1128/msystems.00457-24. PMID: 39660865. Laboratory investigation. ˍ

Ozeki Y, Honda-Kitahara M, Yanagisawa S, Takahashi M, Ohno M, Miyakita Y, Kikuchi M, Nakano T, Hosoya T, Sugino H, Satomi K, Yoshida A, Igaki H, Kubo Y, Ichimura K, Suzuki H, Masutomi K, Kondo A, Narita Y.
Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)-mutant astrocytoma may indicate radiation necrosis.
Jpn J Clin Oncol. 2024 Dec 11:hyae151. doi: 10.1093/jjco/hyae151. PMID: 39660448. Observational study˰ ˍ

Eldaya RW, Kaya D, Williams M, Calle S, Schellingerhout D.
Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma: A Single Center Case Series.
AJNR Am J Neuroradiol. 2024 Dec 12. doi: 10.3174/ajnr.A8521. PMID: 39667825. Case report˰ ˍ

Batista NM, Corrigan M, Chen JG.
Procedural sedation performed by pediatric critical care physicians for children undergoing daily radiation therapy is effective and safe.
Pediatr Hematol Oncol. 2024 Dec 13:1-9. doi: 10.1080/08880018.2024.2436496. PMID: 39673074. Observational study˰ ˍ

*Cheng S, McLaughlin JR, Brown MC, Rutka J, Bouffet E, Hawkins C, Cairney AE, Ranger A, Fleming AJ, Johnston DL, Greenberg M, Malkin D, Hung RJ.
Birth characteristics and the risk of childhood brain tumors: A case-control study in Ontario, Canada.
Int J Cancer. 2024 Dec 13. doi: 10.1002/ijc.35287. PMID: 39670564. Observational study˰ ˍ

*Lyukmanova EN, Kirichenko AV, Medyanik IA, Yashin KS, Kirpichnikov MP, Bychkov ML.
Extracellular Vesicles from Plasma of Patients with Glioblastoma Promote Invasion of Glioblastoma Cells Even After Tumor Resection.
Biomedicines. 2024 Dec 13;12(12):2834. doi: 10.3390/biomedicines12122834. PMID: 39767739. Laboratory investigation. ˍ

Nagoshi N, Okubo T, Ozaki M, Suzuki S, Takeda K, Iga T, Matsumoto M, Nakamura M, Watanabe K.
Epidemiology and surgical outcomes of pediatric intradural spinal tumors: results from a retrospective series of patients operated in the first two decades of life.
Spinal Cord. 2024 Dec 13. doi: 10.1038/s41393-024-01052-y. PMID: 39672822. Observational study˰ ˍ

Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M, Lewis LD, Schiff D, Fadul CE, Chamberlain M, Kesari S, Ahluwalia M, Ghosh D, Sonabend AM, Kumthekar P.
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.
Neurooncol Adv. 2024 Dec 14;6(1):vdae186. doi: 10.1093/noajnl/vdae186. PMID: 39713041. Interventional study. ˍ

Ersöz CC, Berber H, Heper A.
"Grade 4 Astrocytoma vs Grade 4 Glioblastoma: Is there any clue in H&E?".
Int J Neurosci. 2024 Dec 16:1-6. doi: 10.1080/00207454.2024.2441994. PMID: 39686561. Observational study. ˍ

Negm L, Chung J, Nobre L, Bennett J, Fernandez NR, Nunes NM, Liu ZA, Komosa M, Aronson M, Zhang C, Stengs L, Bianchi V, Edwards M, Doherty S, Ercan AB, Cardenas MF, Macias M, Lueder MR, Ku M, Johnson M, Chang Y, Dimayacyac JR, Kraya AA, Guo Y, Naky S, Keith J, Gao AF, Munoz DG, Nguyen L, Tsang DS, Lim-Fat MJ, Das S, Shlien A, Ramaswamy V, Huang A, Malkin D, Villani A, Ertl-Wagner B, Levine A, Robinson GW, Pollock BH, Spector LG, Sei S, Dirks PB, Getz G, Nichols KE, Resnick AC, Wheeler DA, Das A, Maruvka YE, Hawkins C, Tabori U.
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study.
Lancet Oncol. 2024 Dec 16:S1470-2045(24)00640-5. doi: 10.1016/S1470-2045(24)00640-5. PMID: 39701117. Observational study˰ ˍ

Westermann CR, Davidson TB, Waters K, Margol AS, Cheung CC.
Immune checkpoint inhibitors and endocrinopathies in pediatric brain tumor patients.
J Pediatr Endocrinol Metab. 2024 Dec 16. doi: 10.1515/jpem-2024-0243. PMID: 39680426. Observational study. ˍ

Chen H, Tan G, Zhong L, Hu Y, Han W, Huang Y, Liang Q, Szekeres D, Jiang H, Bharadwaj R, Smith SM, Wang HZ, Liu X.
MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.
J Neurooncol. 2024 Dec 17. doi: 10.1007/s11060-024-04910-0. PMID: 39688766. Observational study. ˍ

Jang H, Moon S, Kwon HJ, Lee S, Choe G, Lee KS.
Genetic alteration analysis of non-pediatric diffuse midline glioma, H3 K27-altered.
Hum Pathol. 2024 Dec 17:105709. doi: 10.1016/j.humpath.2024.105709. PMID: 39701425. Observational study˰ ˍ

Zauderer MG, Jegede O, Jackman DM, Zwiebel JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Takebe N, Huang R, Carrillo JA, Brenner AJ, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U.
JCO Precis Oncol. 2024 Dec 18;8:e2400327. doi: 10.1200/PO.24.00327. PMID: 39693587. Interventional study˰ ˍ

Zhang X, Zheng Z, Guo X, Wang H, Gong L, Wang Y, Guo F, Ma W.
Risk Prediction and Management for Central Nervous System Infection After Resection for Gliomas-The 8-Year Experience from a Tertiary Medical Center.
J Clin Med. 2024 Dec 18;13(24):7733. doi: 10.3390/jcm13247733. PMID: 39768656. Observational study. ˍ

Nysom K, Kilburn LB, Leary SES, Landi DB, de Vos-Kerkhof E, Perreault S, Witt O, Ziegler DS, Hernáiz Driever P, Franson AT, Baxter PA, Whipple NS, Kline C, Segal D, Jabado N, Bailey S, McCowage G, Hansford JR, Khuong-Quang DA, Gottardo NG, Hassall T, Han JW, Yalon Oren M, Chi SN, Qiu J, Da Costa D, Govinda Raju S, Manley P, Hargrave D.
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.
Neuro Oncol. 2024 Dec 19:noae274. doi: 10.1093/neuonc/noae274. PMID: 39700439. Observational study. ˍ

Bauchet L, Rigau V, Mathon B, Darlix A; With the participation of the Société Française de Neurochirurgie (SFNC), Club de Neuro-oncologie of SFNC, Société Française de Neuropathologie (SFNP) and Association des Neuro-Oncologues d’Expression Française (ANOCEF).
Epidemiological analysis of adult-type diffuse lower-grade gliomas and incidence and prevalence estimates of diffuse IDH-mutant gliomas in France.
Neurochirurgie. 2024 Dec 20:101627. doi: 10.1016/j.neuchi.2024.101627. PMID: 39710298. Observational study. ˍ

Duan H, He Z, Chen Z, Chen Y, Hu W, Sai K, Zhang X, Xia J, Li Y, Liu R, Zou C, Chen Z, Mou Y.
Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.
BMC Immunol. 2024 Dec 20;25(1):83. doi: 10.1186/s12865-024-00676-2. PMID: 39707189. Observational study. ˍ